NCT02921477View on ClinicalTrials.gov

Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias

PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions

Mild Cognitive ImpairmentDementia

Interventions

DRUG

bosutinib

Trial Locations (1)

90403

Neurological Associates of West LA, Santa Monica

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Neurological Associates of West Los Angeles

OTHER

NCT02921477 - Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias | Biotech Hunter | Biotech Hunter